Anvimo 240 mg Injection | Nivolumab | Immunotherapy | Oncology Medicine Supplier
Anvimo 240 mg Injection contains Nivolumab, a monoclonal antibody used in cancer immunotherapy. It works by enhancing the body’s immune response to help detect and fight cancer cells under medical supervision.
🔍 Keywords
Nivolumab Injection 240 mg, Immunotherapy Drug, Cancer Treatment Medicine, PD-1 Inhibitor, Oncology Injection Supplier, Pharma Exporter India
🔹 Product Category
Oncology Medicine | Immunotherapy | Monoclonal Antibody
🔹 Composition
Nivolumab 240 mg
🔹 Uses / Indications
✔ Lung cancer (NSCLC)
✔ Melanoma
✔ Kidney cancer (Renal Cell Carcinoma)
✔ Head & neck cancers
✔ Other cancers (as prescribed)
🔹 Key Benefits
✔ Boosts immune system against cancer
✔ Targeted immunotherapy approach
✔ Improves survival outcomes in many cancers
✔ Widely used in advanced oncology care
🔹 Dosage & Administration
✔ Intravenous infusion
✔ Administered under oncologist supervision
✔ Dosage as per treatment protocol
🔹 Packaging & Supply
✔ Vial Injection
✔ Cold-chain export packaging available
✔ Bulk supply supported
🔹 Storage Instructions
✔ Store at 2–8°C
✔ Do not freeze
✔ Protect from light
🔹 Certifications
✔ WHO-GMP Certified
✔ COA & COPP Available
🌍 Global Export Supply
USA, UK, UAE, Singapore, India, Philippines, Vietnam, South Africa, Nigeria, Kenya, Brazil, Mexico, Peru
📍 Location: Nagpur, Maharashtra, India
📞 Contact for Bulk Orders
+91 8007161282
+91 9970011496
📧 Email: sales@pacificmedicines.com
🔖 Hashtags
#Nivolumab #Immunotherapy #CancerTreatment #Oncology #MonoclonalAntibody #PharmaExport #GlobalPharma #B2BHealthcare #MedicalSupply #IndiaPharma
